Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk

被引：46
作者：
Baxter, SW [1 ]
Campbell, IG [1 ]
机构：
[1] Peter MacCallum Canc Inst, Victorian Breast Canc Res Consortium, Canc Genet Lab, E Melbourne, Vic 8006, Australia
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2001年 / 93卷 / 07期
关键词：
D O I：
10.1093/jnci/93.7.557
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：557 / 558
页数：2
相关论文
共 7 条
[1]   Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk [J].
Ameyaw, MM ;
Thornton, N ;
McLeod, HL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (23) :1947-1947
[2]  
Aunoble B, 2000, INT J ONCOL, V16, P567
[3]   Prognostic relavance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy [J].
Gregory, RK ;
Powles, TJ ;
Salter, J ;
Chang, JC ;
Ashley, S ;
Dowsett, M .
BREAST CANCER RESEARCH AND TREATMENT, 2000, 59 (02) :171-175
[4]   G-POLYMORPHISM TO A-POLYMORPHISM AT AMINO-ACID CODON 655 OF THE HUMAN ERBB-2/HER2 GENE [J].
PAPEWALIS, J ;
NIKITIN, AY ;
RAJEWSKY, MF .
NUCLEIC ACIDS RESEARCH, 1991, 19 (19) :5452-5452
[5]   The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells [J].
Pegram, MD ;
Finn, RS ;
Arzoo, K ;
Beryt, M ;
Pietras, RJ ;
Slamon, DJ .
ONCOGENE, 1997, 15 (05) :537-547
[6]   HUMAN-BREAST CANCER - CORRELATION OF RELAPSE AND SURVIVAL WITH AMPLIFICATION OF THE HER-2 NEU ONCOGENE [J].
SLAMON, DJ ;
CLARK, GM ;
WONG, SG ;
LEVIN, WJ ;
ULLRICH, A ;
MCGUIRE, WL .
SCIENCE, 1987, 235 (4785) :177-182
[7]   Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk [J].
Xie, DW ;
Shu, XO ;
Deng, ZL ;
Wen, WQ ;
Creek, KE ;
Dai, Q ;
Gao, YT ;
Jin, F ;
Zheng, W .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (05) :412-417
1